Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pfeffer

Showing results (541-550 of 754) with videos related to

Pageof 76
Sort By:
Journal of the American College of Cardiology|May 3, 2002
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarctionLeonardo A M Zornoff, Hicham Skali, Marc A Pfeffer, et al.
Circulation|June 17, 1997
Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trialM A Pfeffer, S C Greaves, J M Arnold, et al.
European Journal of Heart Failure|October 2, 2015
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney diseaseNatalie A Bello, Eldrin F Lewis, Akshay S Desai, et al.
Circulation. Heart Failure|November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trialAmil M Shah, Sanjiv J Shah, Inder S Anand, et al.
JAMA Network Open|March 24, 2025
Physician Perspectives on Ambient AI ScribesShreya J Shah, Trevor Crowell, Yejin Jeong, et al.
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
Heart Rhythm|March 8, 2007
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experienceKent Stephenson, Hicham Skali, John J V McMurray, et al.
JACC. Heart Failure|January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney DiseaseIris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
European Heart Journal. Acute Cardiovascular Care|January 17, 2023
Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MIElke Platz, Brian Claggett, Karola S Jering, et al.
American Journal of Nephrology|December 15, 2017
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy TrialFinnian R Mc Causland, Brian Claggett, Marc A Pfeffer, et al.
Pageof 76

Showing results (541-550 of 754) with videos related to

Sort By:
Pageof 76
Journal of the American College of Cardiology|May 3, 2002
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarctionLeonardo A M Zornoff, Hicham Skali, Marc A Pfeffer, et al.
Circulation|June 17, 1997
Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trialM A Pfeffer, S C Greaves, J M Arnold, et al.
European Journal of Heart Failure|October 2, 2015
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney diseaseNatalie A Bello, Eldrin F Lewis, Akshay S Desai, et al.
Circulation. Heart Failure|November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trialAmil M Shah, Sanjiv J Shah, Inder S Anand, et al.
JAMA Network Open|March 24, 2025
Physician Perspectives on Ambient AI ScribesShreya J Shah, Trevor Crowell, Yejin Jeong, et al.
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
Heart Rhythm|March 8, 2007
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experienceKent Stephenson, Hicham Skali, John J V McMurray, et al.
JACC. Heart Failure|January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney DiseaseIris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
European Heart Journal. Acute Cardiovascular Care|January 17, 2023
Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MIElke Platz, Brian Claggett, Karola S Jering, et al.
American Journal of Nephrology|December 15, 2017
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy TrialFinnian R Mc Causland, Brian Claggett, Marc A Pfeffer, et al.
Pageof 76